Salivary Gland Tumors Diagnosis and Treatment
Salivary Gland Tumors Diagnosis and Treatment is a research topic within Surgery. Science Explorer counts 33k research works in it since 1950. 9.4% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the pathology, genetics, diagnosis, and treatment of various salivary gland tumors and carcinomas, including adenoid cystic carcinoma, mucoepidermoid carcinoma, mammary analogue secretory carcinoma, and myoepithelial tumors. It explores molecular classifications, prognostic factors, fusion genes, fine-needle aspiration cytology, and the role of radiotherapy in the management of these tumors.
- Salivary Gland Tumors
- Adenoid Cystic Carcinoma
- Mucoepidermoid Carcinoma
- Mammary Analogue Secretory Carcinoma
- Myoepithelial Tumors
- ETV6-NTRK3 Fusion Gene
- Fine-Needle Aspiration Cytology
- Radiotherapy
- Molecular Classification
- Prognostic Factors
- Research works
- 33k fractional, since 1950
- In the world top 10%
- 3.1k per year above
- Top-10% rate
- 9.4% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +11% the tick is no change
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Salivary Gland Tumors Diagnosis and Treatment research?
By volume, the United States and India publish the most (843 and 646 works in 2022–2025).
By volume, 2022–2025
- 1 United States 843 works
- 2 India 646 works
- 3 China 644 works
- 4 Japan 401 works
- 5 Brazil 194 works
- 6 Italy 193 works
- 7 Germany 193 works
- 8 United Kingdom 158 works
- 9 Türkiye 133 works
- 10 South Korea 121 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Salivary Gland Tumors Diagnosis and Treatment research?
By volume in 2022–2025, All India Institute of Medical Sciences publishes the most Salivary Gland Tumors Diagnosis and Treatment research, followed by The University of Texas MD Anderson Cancer Center and Alexandria University.
By volume, 2022–2025
- 1 All India Institute of Medical SciencesIndia 28 works
- 2 The University of Texas MD Anderson Cancer CenterUnited States 24 works
- 3 Alexandria UniversityEgypt 23 works
- 4 L V Prasad Eye InstituteIndia 20 works
- 5 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 19 works
- 6 Sichuan UniversityChina 17 works
- 7 Institute of Medical SciencesIndia 17 works
- 8 Saveetha UniversityIndia 16 works
- 9 Memorial Sloan Kettering Cancer CenterUnited States 16 works
- 10 Sun Yat-sen UniversityChina 14 works
Where is Salivary Gland Tumors Diagnosis and Treatment research done?
The largest centres of Salivary Gland Tumors Diagnosis and Treatment research in 2022–2025 are Beijing (China), Tokyo (Japan), Shanghai (China) and Seoul (South Korea).
Largest cities, 2022–2025
Where is the best place to study Salivary Gland Tumors Diagnosis and Treatment?
Among universities, judged by research, Alexandria University, All India Institute of Medical Sciences and Institute of Medical Sciences score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | Alexandria UniversityEgypt | 68.4 | 10.2% | 10.3× | 23 | +70.6% |
| 2 | All India Institute of Medical SciencesIndia | 55.5 | 3.9% | 9.6× | 28 | +58.9% |
| 3 | Institute of Medical SciencesIndia | 49.9 | 0.0% | 11.1× | 17 | +129.8% |
| 4 | Harvard UniversityUnited States | 45.0 | 19.6% | 1.9× | 11 | +48.0% |
| 5 | Osaka University of Pharmaceutical SciencesJapan | 45.0 | 9.1% | 33.4× | 9 | — |
| 6 | Saveetha UniversityIndia | 43.5 | 4.1% | 3.5× | 16 | +363.9% |
| 7 | Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina | 42.8 | 13.6% | 4.2× | 20 | -19.6% |
| 8 | Universidade Estadual de Campinas (UNICAMP)Brazil | 41.0 | 14.1% | 3.9× | 14 | +16.2% |
| 9 | All India Institute of Medical Sciences BhubaneswarIndia | 38.6 | 5.3% | 13.9× | 8 | — |
| 10 | Sağlık Bilimleri ÜniversitesiTürkiye | 36.6 | 3.5% | 5.0× | 14 | — |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Salivary Gland Tumors Diagnosis and Treatment research growing?
Output in 2018–2022 was 11% higher than in 2013–2017, peaking in 2021. The fastest-growing topics are Salivary Gland Tumors Diagnosis and Treatment.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.